| Product NDC: | 68774-600 |
| Proprietary Name: | VoSpire |
| Non Proprietary Name: | Albuterol Sulfate |
| Active Ingredient(s): | 4 mg/1 & nbsp; Albuterol Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68774-600 |
| Labeler Name: | DAVA Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076130 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020930 |
| Package NDC: | 68774-600-01 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68774-600-01) |
| NDC Code | 68774-600-01 |
| Proprietary Name | VoSpire |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68774-600-01) |
| Product NDC | 68774-600 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Albuterol Sulfate |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20020930 |
| Marketing Category Name | ANDA |
| Labeler Name | DAVA Pharmaceuticals, Inc. |
| Substance Name | ALBUTEROL SULFATE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |